HAEMOPHILIA A (MODERATE OR SEVERE)

Clinical trials for HAEMOPHILIA A (MODERATE OR SEVERE) explained in plain language.

Never miss a new study

Get alerted when new HAEMOPHILIA A (MODERATE OR SEVERE) trials appear

Sign up with your email to follow new studies for HAEMOPHILIA A (MODERATE OR SEVERE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Weekly treatment aims to protect hemophilia Patients' joints

Disease control Ongoing

This study is checking if a weekly preventative treatment called efanesoctocog alfa can improve joint health in people with moderate or severe Hemophilia A. It will follow about 37 patients in Europe for 12 months, using ultrasound and MRI scans to see if the treatment reduces jo…

Matched conditions: HAEMOPHILIA A (MODERATE OR SEVERE)

Phase: PHASE4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

HAEMOPHILIA A (MODERATE OR SEVERE)

Get alerted when new HAEMOPHILIA A (MODERATE OR SEVERE) trials appear

Weekly treatment aims to protect hemophilia Patients' joints